Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Where's the VOLUME?
View:
Post by TMAZZ21 on Nov 28, 2022 1:25pm

Where's the VOLUME?

My only question is - Where's the volume????

Volume speaks volume of what is or isn't happening!!

So where's the volume??

Can someone tell me where's the VOLUME??
Comment by Angler101 on Nov 28, 2022 1:40pm
Most of the volume right now is in your big mouth....I’d be happy to pump up the volume for you, if you like
Comment by TMAZZ21 on Nov 28, 2022 2:53pm
You know what buddy, Your WACKED! What's your issue?
Comment by Angler101 on Nov 28, 2022 3:21pm
My issue is that I hate intellectually challenged individuals like yourself that post ridiculous rants pretending they’re shareholders and are dumb enough to think they’re actually fooling anyone.
Comment by TMAZZ21 on Nov 28, 2022 3:52pm
Surely don't believe me, I only have a small number of shares - 6000 in total Of course I want to add more but I'm not seeing the volume coming in! I need to see a million shares traded on the Nasdaq before I add more!
Comment by TMAZZ21 on Nov 28, 2022 4:00pm
AS AGENTS, WE TODAY CONFIRM THE FOLLOWING BUY FOR YOUR ACCOUNT ON MULTIPLE CANADIAN MARKETPLACES. DETAILS ARE AVAILABLE UPON REQUEST. NOVEMBER 16, 2022 SETTLEMENT DATE NOVEMBER 18, 2022 ACCOUNT NO. −CASH TRANSACTION TYPE BOUGHT REFERENCE G6854 / CUSIP  Quantity Security Description Unit Price 6,000 ONCOLYTICS BIOTECH INC @ 2.0073C$ COM NEW AVG PRICE SHOWN−DETAILS ON REQ STP PET INVESTMENT ...more  
Comment by Angler101 on Nov 28, 2022 4:01pm
Cmon man.........you’re young......get a REAL job.....something you’ll be proud of......and people might even be proud of You....how about something that’s beneficial to society and appreciated by the people around you...get a job where you actually have to accomplish something more than just wackin that keyboard all day and trying to con and manipulate good, peaceful decent people........... ...more  
Comment by TMAZZ21 on Nov 28, 2022 5:40pm
Your a loss cause buddy it's time you moved on sale your shares and find another train to no where!
Comment by Buckhenry on Nov 28, 2022 3:40pm
so so sorry you feel that way... with lots of therapy you may get over it. besides I do not say things fir you to like... I say them because they need to be said to keep you forever pumpers and wishers in check. this stock could very well do something but not because of most of the garbage said on here. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities